Singapore markets close in 5 hours 20 minutes

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
49.71-1.02 (-2.01%)
At close: 04:04PM EST
49.65 -0.06 (-0.12%)
After hours: 07:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous close50.73
Open50.67
Bid49.81 x 1000
Ask49.71 x 1100
Day's range49.18 - 50.85
52-week range41.45 - 61.71
Volume21,770,577
Avg. volume20,229,980
Market cap279.038B
Beta (5Y monthly)0.65
PE ratio (TTM)9.52
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.60 (3.14%)
Ex-dividend date03 Nov 2022
1y target estN/A
  • Business Wire

    Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease

    NEW YORK & CAMBRIDGE, Mass., December 06, 2022--Pfizer Inc. (NYSE: PFE) and Clear Creek Bio, Inc. today announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARS-CoV-2 papain-like protease (PLpro) for the oral treatment of COVID-19. PLpro is an essential enzyme, which, along with the main protease (Mpro), plays an important role in viral replication. This program will expand Pfizer’s innovative anti-infective p

  • Business Wire

    Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day

    NEW YORK, December 01, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term Launches + High-Value Pipeline Day on Monday, December 12, 2022 from 1:00 p.m. EST to 6:00 p.m. EST, with an approximately 30 minute break at the midpoint. Pfizer business executives and scientific leadership will provide updates on the company’s potential near-term product launches and key high-value pipeline programs, both of which are expected to be pri

  • Business Wire

    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

    NEW YORK, November 28, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business; Kevin Sullivan, Global Specialty Care & U.S. President; and Navin Katyal, U.S. Commercial and Global Business Lead for mRNA Portfolio, at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 4:20 p.m. EST.